Luteolin and Quercetin combination therapy: Enhanced inhibition of H157 human lung cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Luteolin and Quercetin combination therapy: Enhanced inhibition of H157 human lung cancer cells

Published:2024-09 Issue: Volume:12 Page:100479
ISSN:2667-1425
Container-title:Pharmacological Research - Modern Chinese Medicine
language:en
Short-container-title:Pharmacological Research - Modern Chinese Medicine

Author:

Wang Yinchuan,Chen Jiacheng,Li Zhanglong,Liu Susu,Liu Yuan,Yu Changyuan,Liu Jiahui,Wang Shihui

Funder

National Key Research and Development Program of China

National Key Project for Synthetic Biology

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference30 articles.

1. Interpretation on the report of global cancer statistics 2020;Liu;J. Multidiscip. Cancer Manag. (Electr. Version),2021

2. Advances in molecular mechanism of lung cancer: from rational to practice;Jin;China Oncol.,2020

3. Cancer statistics, 2010;Ahmedin;CA Cancer J. Clin.,2010

4. Progress in the treatment of lung cancer by iron death induced by traditional chinese medicine;Jiang;Acta Chin. Med. Pharmacol.,2024

5. Synergism and attenuation effect of traditional Chinese medicine combined with chemotherapy in the treatment of advanced non-small cell lung cancer;Dou;Heilongjiang J. Tradit. Chin. Med.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP